Tower Research Capital (TRC)’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-647
Closed -$7K 6577
2023
Q1
$7K Sell
647
-10
-2% -$108 ﹤0.01% 4807
2022
Q4
$7K Sell
657
-330
-33% -$3.52K ﹤0.01% 4663
2022
Q3
$10K Sell
987
-2
-0.2% -$20 ﹤0.01% 4615
2022
Q2
$10K Buy
+989
New +$10K ﹤0.01% 4518
2021
Q2
Sell
-1
Closed 6032
2021
Q1
$0 Buy
+1
New ﹤0.01% 5871